Louise Bordeleau

Louise Bordeleau

UNVERIFIED PROFILE

Are you Louise Bordeleau?   Register this Author

Register author
Louise Bordeleau

Louise Bordeleau

Publications by authors named "Louise Bordeleau"

Are you Louise Bordeleau?   Register this Author

34Publications

426Reads

45Profile Views

Cancer prevention and screening in a BRCA2-positive male to female transgender patient.

Breast J 2018 11 23;24(6):1112-1113. Epub 2018 Jul 23.

McMaster University - Surgery, Hamilton, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/tbj.13096DOI Listing
November 2018

National Cancer Institute Breast Cancer Steering Committee Working Group Report on Meaningful and Appropriate End Points for Clinical Trials in Metastatic Breast Cancer.

J Clin Oncol 2018 Sep 13:JCO1800242. Epub 2018 Sep 13.

Andrew D. Seidman, Memorial Sloan Kettering Cancer Center; Dawn L. Hershman, Columbia University, New York, NY; Louise Bordeleau, Hamilton Health Sciences and Canadian Cancer Trials Group, Hamilton, Ontario, Canada; Louis Fehrenbacher, Kaiser Permanente, Vallejo, CA; William E. Barlow, Cancer Research and Biostatistics, Seattle, WA; Jane Perlmutter, Gemini Group, Ann Arbor, MI; Lawrence Rubinstein, Jennifer Fallas Hayes, and Larissa A. Korde, National Cancer Institute; Lynn Pearson Butler, The Emmes Corporation, Rockville; Suparna B. Wedam, Julia A. Beaver, and Laleh Amiri-Kordestani, US Food and Drug Administration, Silver Spring; Jo Anne Zujewski, JZ Oncology, Bethesda, MD; Mary Lou Smith, Research Advocacy Network, Plano, TX; Meredith M. Regan, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; and Priya Rastogi, University of Pittsburgh Medical Center, Pittsburgh, PA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.18.00242
Publisher Site
http://dx.doi.org/10.1200/JCO.18.00242DOI Listing
September 2018

Pharmacoeconomics of systemic therapies for lung cancer.

Authors:
Louise Bordeleau

Treat Respir Med 2006 ;5(2):129-41

Department of Medicine, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
April 2016

Prospective Evaluation of the 21-Gene Recurrence Score Assay for Breast Cancer Decision-Making in Ontario.

J Clin Oncol 2016 Apr 23;34(10):1065-71. Epub 2015 Nov 23.

Mark N. Levine, Jim A. Julian, and Louise Bordeleau, McMaster University, Hamilton; Mark N. Levine and Louise Bordeleau, Hamilton Health Sciences Juravinski Cancer Centre, Hamilton; Mark N. Levine and Jim A. Julian, Ontario Clinical Oncology Group and Escarpment Cancer Research Institute, Hamilton; Philippe L. Bedard, Andrea Eisen, Maureen E. Trudeau, and Kathleen I. Pritchard, University of Toronto, Toronto; Phillipe L. Bedard, Princess Margaret Hospital, Toronto; Andrea Eisen, Maureen E. Trudeau, and Kathleen I. Pritchard, Odette Sunnybrook Regional Cancer Centre; Toronto; and Brian Higgins, Peel Regional Cancer Centre, Mississauga, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.62.8503DOI Listing
April 2016

Response to Suissa and Azoulay. The association of basal insulin glargine and/or n-3 fatty acids with incident cancers in patients with dysglycemia. Diabetes Care 2014;37:1360-1366.

Diabetes Care 2014 Oct;37(10):e217

Department of Medicine, Population Health Research Institute, McMaster University, Hamilton Health Sciences, Hamilton, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dc14-1220DOI Listing
October 2014

Response to Zanders et al. The association of basal insulin glargine and/or n-3 fatty acids with incident cancers in patients with dysglycemia. Diabetes Care 2014;37:1360-1366.

Diabetes Care 2014 Oct;37(10):e223

Department of Medicine, Population Health Research Institute, McMaster University, Hamilton Health Sciences, Hamilton, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dc14-1567DOI Listing
October 2014

A fatal case of Pneumocystis jirovecii pneumonia in a breast cancer patient receiving weekly paclitaxel and trastuzumab.

J Oncol Pharm Pract 2012 Jun 12;18(2):293-5. Epub 2011 Sep 12.

Department of Pharmacy, Princess Margaret Hospital, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.1177/1078155211412991
Publisher Site
http://dx.doi.org/10.1177/1078155211412991DOI Listing
June 2012

Chemotherapy-induced infiltrative pneumonitis cases in breast cancer patients.

J Oncol Pharm Pract 2012 Jun 4;18(2):311-5. Epub 2012 Jan 4.

Department of Pharmacy, Princess Margaret Hospital, Toronto, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1078155211429384DOI Listing
June 2012

Willingness of breast cancer survivors to participate in a randomized controlled trial of digital mammography with or without MRI as breast cancer surveillance: a feasibility study.

Breast 2011 Feb 9;20(1):96-8. Epub 2010 Sep 9.

Department of Medical Oncology, Sunnybrook Odette Cancer Centre, The University of Toronto, 2075 Bayview Ave., Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.breast.2010.08.006DOI Listing
February 2011

Quality-of-life measurement in randomized clinical trials in breast cancer: an updated systematic review (2001-2009).

J Natl Cancer Inst 2011 Feb 7;103(3):178-231. Epub 2011 Jan 7.

Santé des populations: Unité de recherche en santé des populations (URESP), Centre de recherche FRSQ du Centre hospitalier affilié universitaire de Québec (CHA), Service d'hémato-oncologie du CHA and Centre des Maladies du Sein Deschênes-Fabia du CHA, Quebec City, QC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djq508DOI Listing
February 2011

Multicenter, randomized, cross-over clinical trial of venlafaxine versus gabapentin for the management of hot flashes in breast cancer survivors.

J Clin Oncol 2010 Dec 8;28(35):5147-52. Epub 2010 Nov 8.

Department of Oncology, Juravinski Cancer Centre, 699 Concession St, Hamilton, Ontario, Canada L8V 5C2.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2010.29.9230DOI Listing
December 2010

Breast cancer in a BRCA2 mutation carrier with a history of prostate cancer.

Nat Rev Clin Oncol 2009 Oct;6(10):604-7

University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrclinonc.2009.116DOI Listing
October 2009

Selecting a BRCA risk assessment model for use in a familial cancer clinic.

BMC Med Genet 2008 Dec 22;9:116. Epub 2008 Dec 22.

Mount Sinai Hospital, Marvelle Koffler Breast Centre, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2350-9-116DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2630980PMC
December 2008

Identification of cancer care and protocol characteristics associated with recruitment in breast cancer clinical trials.

J Clin Oncol 2008 Sep;26(27):4458-65

Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital St-Sacrement, Québec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2007.15.3726DOI Listing
September 2008

Treating dural metastases mimicking intracranial hypotension.

J Support Oncol 2007 Oct;5(9):423-4

View Article

Download full-text PDF

Source
October 2007

Responsiveness to change [corrected] due to supportive-expressive group therapy, improvement in mood and disease progression in women with metastatic breast cancer.

Qual Life Res 2007 Aug 15;16(6):1007-17. Epub 2007 May 15.

Département d'hématologie, Unité de recherche en santé des populations, Centre hospitalier affilié universitaire de Québec, pavillon St-Sacrement, Quebec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11136-007-9208-2DOI Listing
August 2007

Three methods for minimally important difference: no relationship was found with the net proportion of patients improving.

J Clin Epidemiol 2007 May 11;60(5):448-55. Epub 2006 Dec 11.

Unité de recherche en santé des populations, Centre de recherche, Hôpital du Saint-Sacrement, Quebec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jclinepi.2006.08.006DOI Listing
May 2007

Therapeutic options for the management of hot flashes in breast cancer survivors: an evidence-based review.

Clin Ther 2007 Feb;29(2):230-41

Department of Medical Oncology, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clinthera.2007.02.006DOI Listing
February 2007

Management of the BRCA mutation carrier or high-risk patient.

Clin Plast Surg 2007 Jan;34(1):15-27; abstract v

Department of Medical Oncology, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cps.2006.11.010DOI Listing
January 2007

Health-related quality of life and psychosocial status in breast cancer prognosis: analysis of multiple variables.

J Clin Oncol 2004 Oct;22(20):4184-92

Mount Sinai Hospital, 1284-600 University Avenue, Toronto, Ontario M5G 1X4, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2004.12.091DOI Listing
October 2004

Clinical manifestations associated with the aberrant expression of the soluble granulocyte-macrophage colony-stimulating factor receptor in patients presenting with haematological malignancies.

Br J Haematol 2003 Apr;121(1):86-93

Department of Medical Oncology, Ontario Cancer Institute/Princess Margaret Hospital, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
April 2003

Health-related quality-of-life measurement in randomized clinical trials in breast cancer--taking stock.

J Natl Cancer Inst 2003 Feb;95(4):263-81

Department of Medicine, Division of Clinical Epidemiology, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, University of Toronto, 1284-600 University Avenue, Toronto, Ontario M5G 1X5, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/95.4.263DOI Listing
February 2003